Literature DB >> 30136550

Idiopathic Pulmonary Fibrosis.

Venerino Poletti1, Sara Tomassetti2, Claudia Ravaglia2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30136550     DOI： 10.1056/NEJMc1807508

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Efficacy of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial.

Authors:  Zhen-Hui Lu; Chun-Li Yang; Gai-Ge Yang; Wen-Xu Pan; Li-Guang Tian; Jin-Xin Zheng; Shan Lv; Shao-Yan Zhang; Pei-Yong Zheng; Shun-Xian Zhang
Journal:  Infect Dis Poverty       Date:  2021-03-18       Impact factor: 4.520

2.  S100A9/CD163 expression profiles in classical monocytes as biomarkers to discriminate idiopathic pulmonary fibrosis from idiopathic nonspecific interstitial pneumonia.

Authors:  Masahiro Yamashita; Yuh Utsumi; Hiromi Nagashima; Hiroo Nitanai; Kohei Yamauchi
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

3.  A novel gene signature based on the hub genes of COVID-19 predicts the prognosis of idiopathic pulmonary fibrosis.

Authors:  Run Guo; Yuefei Zhou; Fang Lin; Mengxing Li; Chunting Tan; Bo Xu
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.